Literature DB >> 23194089

During apoptosis HMGB1 is translocated into apoptotic cell-derived membranous vesicles.

Martin Schiller1, Petra Heyder, Saskia Ziegler, Anna Niessen, Laura Claßen, Anna Lauffer, Hanns-Martin Lorenz.   

Abstract

High mobility group box protein B1 (HMGB1), a nuclear protein reportedly involved in the structural organisation of DNA, is released from necrotic cells or upon cellular activation. After its release into the extracellular space, HMGB1 serves as a mediator of inflammation. In contrast to necrotic cells, apoptotic ones usually do not release HMGB1. Formation and release of membranous vesicles is a well-known feature of apoptotic cell death. Only recently, subcellular membrane vesicles, such as those released during apoptotic cell death have been identified as immune regulators and as mediators of cell to cell communication. We and others have previously detected nuclear antigens within apoptosis-released membranous vesicles and HMGB1 together with nuclear antigens has been discussed to be a key player in etiology and pathogenesis of autoimmune diseases. On this background, we analysed whether HMGB1 is included in the membranous vesicles generated by apoptosing cells. Employing immune blots we observed abundand amounts of HMGB1 in the fraction of the small membraneous particles isolated from cell culture supernatants and conclude that HMGB1 is translocated into vesicles generated during apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23194089     DOI: 10.3109/08916934.2012.750302

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  22 in total

1.  Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.

Authors:  Yan Chen; Guangping Li; Yanxia Liu; Victoria P Werth; Kevin Jon Williams; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2016-03-09       Impact factor: 6.384

2.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

3.  The expression of HMGB1 on microparticles from Jurkat and HL-60 cells undergoing apoptosis in vitro.

Authors:  D M Spencer; F Mobarrez; H Wallén; D S Pisetsky
Journal:  Scand J Immunol       Date:  2014-08       Impact factor: 3.487

Review 4.  Emerging role of extracellular vesicles in inflammatory diseases.

Authors:  Edit I Buzas; Bence György; György Nagy; András Falus; Steffen Gay
Journal:  Nat Rev Rheumatol       Date:  2014-02-18       Impact factor: 20.543

5.  Pulmonary Epithelial TLR4 Activation Leads to Lung Injury in Neonatal Necrotizing Enterocolitis.

Authors:  Hongpeng Jia; Chhinder P Sodhi; Yukihiro Yamaguchi; Peng Lu; Laura Y Martin; Misty Good; Qinjie Zhou; Jungeun Sung; William B Fulton; Diego F Nino; Thomas Prindle; John A Ozolek; David J Hackam
Journal:  J Immunol       Date:  2016-06-15       Impact factor: 5.422

6.  Desialylation of dying cells with catalytically active antibodies possessing sialidase activity facilitate their clearance by human macrophages.

Authors:  A Tomin; T Dumych; Y Tolstyak; I Kril; I Mahorivska; E Bila; R Stoika; M Herrmann; Y Kit; R Bilyy
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

7.  High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats.

Authors:  Xiaodi Chen; Jiyong Zhang; Boram Kim; Siddhant Jaitpal; Steven S Meng; Kwame Adjepong; Sayumi Imamura; Hidenori Wake; Masahiro Nishibori; Edward G Stopa; Barbara S Stonestreet
Journal:  Exp Neurol       Date:  2018-09-12       Impact factor: 5.330

Review 8.  The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

Review 9.  Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus.

Authors:  Javier Perez-Hernandez; Raquel Cortes
Journal:  Dis Markers       Date:  2015-09-07       Impact factor: 3.434

10.  Lung-derived exosome uptake into and epigenetic modulation of marrow progenitor/stem and differentiated cells.

Authors:  Jason M Aliotta; Mandy Pereira; Edmund H Sears; Mark S Dooner; Sicheng Wen; Laura R Goldberg; Peter J Quesenberry
Journal:  J Extracell Vesicles       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.